Cargando…
New Directions for SMA Therapy
Spinal muscular atrophy (SMA) is a severe disorder of motor neurons and the most frequent genetic cause of mortality in childhood, due to respiratory complications. The disease occurs due to mutations in the survival motor neuron 1 (SMN1) gene that leads to a reduction in the SMN protein, causing de...
Autor principal: | Messina, Sonia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162810/ https://www.ncbi.nlm.nih.gov/pubmed/30200278 http://dx.doi.org/10.3390/jcm7090251 |
Ejemplares similares
-
Gene Therapy in ALS and SMA: Advances, Challenges and Perspectives
por: Lejman, Jan, et al.
Publicado: (2023) -
The clinical landscape for SMA in a new therapeutic era
por: Talbot, K, et al.
Publicado: (2017) -
A new deletion allele of sma-4
por: McKillop, Alexandra N, et al.
Publicado: (2018) -
The effectiveness of styrene-maleic acid (SMA) copolymers for solubilisation of integral membrane proteins from SMA-accessible and SMA-resistant membranes
por: Swainsbury, David J.K., et al.
Publicado: (2017) -
Calcium channels SMA
por: Williams, Ruth
Publicado: (2007)